Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody

Clinical trial NCT05045664 · RECRUITING

Trial details

NCT number: NCT05045664
Sponsor: Heidelberg University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Early Stage Follicular Lymphoma WHO Grade 1/2 or 3a

Start date: 2022-07-06
Primary completion: 2027-09-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.